Janus Henderson Group PLC Increases Position in Core Scientific, Inc. (NASDAQ:CORZ)

Janus Henderson Group PLC lifted its position in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 49.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 88,800 shares of the company's stock after purchasing an additional 29,300 shares during the quarter. Janus Henderson Group PLC's holdings in Core Scientific were worth $1,247,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Core Scientific by 54.3% in the 4th quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company's stock worth $272,270,000 after purchasing an additional 6,819,406 shares during the period. Beryl Capital Management LLC increased its holdings in shares of Core Scientific by 24.3% in the fourth quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company's stock valued at $255,423,000 after purchasing an additional 3,548,396 shares during the period. Driehaus Capital Management LLC boosted its holdings in shares of Core Scientific by 112.1% in the 4th quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company's stock valued at $144,212,000 after acquiring an additional 5,424,901 shares during the last quarter. FMR LLC grew its position in Core Scientific by 2,937.7% during the 4th quarter. FMR LLC now owns 7,436,229 shares of the company's stock worth $104,479,000 after purchasing an additional 7,191,428 shares during the period. Finally, Two Seas Capital LP raised its position in Core Scientific by 9.2% during the fourth quarter. Two Seas Capital LP now owns 6,232,888 shares of the company's stock valued at $87,572,000 after acquiring an additional 527,097 shares in the last quarter.

Insider Transactions at Core Scientific

In other news, Director Todd A. Becker sold 134,250 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the completion of the transaction, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. This represents a 40.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jordan Levy bought 62,500 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was purchased at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the completion of the acquisition, the director now owns 306,887 shares in the company, valued at approximately $2,458,164.87. This trade represents a 25.57% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.40% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. HC Wainwright reissued a "buy" rating and issued a $17.00 price target on shares of Core Scientific in a report on Tuesday, March 11th. Compass Point cut their price objective on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a research report on Tuesday, February 25th. Oppenheimer started coverage on Core Scientific in a research note on Wednesday, May 14th. They issued an "outperform" rating and a $15.00 price target on the stock. Needham & Company LLC restated a "buy" rating and set a $16.00 price target on shares of Core Scientific in a research note on Friday, May 16th. Finally, JMP Securities started coverage on shares of Core Scientific in a research note on Thursday, May 22nd. They set a "market outperform" rating and a $15.00 price target on the stock. Eighteen equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Core Scientific presently has a consensus rating of "Buy" and an average price target of $18.33.

Core Scientific Stock Performance

Shares of NASDAQ CORZ traded down $0.41 during mid-day trading on Wednesday, reaching $10.87. 1,752,302 shares of the company traded hands, compared to its average volume of 13,262,509. The company's fifty day moving average is $8.43 and its two-hundred day moving average is $11.79. Core Scientific, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $18.63. The stock has a market cap of $3.24 billion, a PE ratio of -2.01 and a beta of 6.66.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.02. The firm had revenue of $79.53 million for the quarter, compared to analyst estimates of $92.04 million. During the same period in the previous year, the business posted $0.78 EPS. Core Scientific's revenue for the quarter was down 55.6% compared to the same quarter last year. Research analysts forecast that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.